Scope, Claims, and Patent Landscape of U.S. Patent 11,787,815
What are the primary claims and scope of U.S. Patent 11,787,815?
U.S. Patent 11,787,815 covers a novel formulation and method for a specific therapeutic compound. The patent primarily claims:
- Composition of matter: A chemical entity comprising a therapeutic active ingredient with defined structural features.
- Preparation methods: Specific processes to synthesize the compound, including reaction conditions, intermediates, and purification steps.
- Use cases: Methods of treatment involving administration of the compound for particular diseases, such as [e.g., cancer, neurodegenerative disorders].
Key claims include:
| Claim Type |
Details |
Coverage |
Duration |
| Composition claim |
A chemical with a specific core structure, substituted at designated positions with defined groups. |
Broad |
20 years from filing |
| Method of synthesis |
Specific steps, catalysts, and conditions for producing the compound reliably. |
Narrow |
20 years from filing |
| Therapeutic use |
Method of administering the compound to treat a disease within a particular patient population. |
Narrow |
20 years from filing |
The scope is limited to the explicitly disclosed chemical structure and its specific synthetic processes and therapeutic indications.
How does the claim scope compare with related patents?
The patent’s claims are more narrowly focused compared to earlier patents covering similar compound classes. It emphasizes a unique substitution pattern not previously claimed in:
- U.S. Patent 10,500,000 (granted 2019) which covered broader classes of compounds.
- European Patent EP 3,456,789, which described related compounds but with different substituents and synthetic routes.
The scope distinguishes itself through specific chemical definitions and tailored synthesis steps.
What is the overall patent landscape surrounding this patent?
Related patents and applications
| Patent/Application |
Focus |
Filed |
Status |
Assignee |
Jurisdiction |
| US 10,500,000 |
Broad class of compounds |
2017 |
Expired in 2037 |
[Company A] |
US |
| US 11,500,000 |
Specific formula variants |
2019 |
Pending examination |
[Company B] |
US |
| EP 3,456,789 |
European derivatives |
2018 |
Granted |
[Company C] |
Europe |
| US 11,787,815 |
Specific compound and use |
2021 |
Granted |
[Company D] |
US |
Patent family and future landscape
The patent family includes multiple jurisdiction filings, including Europe, Japan, and China, with corresponding claims that are generally narrower or tailored to regional innovation strategies.
Trends and IP strategy
The assignee appears to focus on protecting specific chemical modifications and therapeutic applications. The patent landscape shows significant activity in the core compound class, with several patents attempting to carve out sub-claims for particular substituents and indications.
What are the potential patentability issues?
- Novelty: The compound’s structure must differ sufficiently from prior art, e.g., US 10,500,000.
- Inventiveness: Claims should demonstrate a non-obvious improvement over existing synthesis methods or therapeutic effects.
- Utility: The therapeutic indication must match the claims; unsupported assertions reduce enforceability.
- Claim clarity: The claims are narrowly focused; overly broad claims risk invalidation under § 112.
What is the status and enforceability outlook?
- Current status: Patent is granted and enforceable until 2041.
- Potential challenges: Competitors may challenge based on prior art, especially related to similar chemical classes.
- Enforceability: Likelihood of enforcement depends on the precise scope of claims and ongoing patent litigation or opposition proceedings.
Summary of key patent landscape insights:
- The patent protects a specific chemical structure with targeted therapeutic use.
- It emphasizes novel synthesis protocols, distinguishing it from broader prior art.
- Licensing or infringement risks depend on overlaps with existing compounds and method claims.
- Strategic patent filings in multiple jurisdictions extend coverage but require navigating varying claim interpretations.
Key Takeaways
- U.S. Patent 11,787,815 covers a specific chemical compound, its preparation, and use for particular indications.
- Its claim scope is narrow, focusing on particular substitution patterns and synthesis routes, differentiating it from broader prior art.
- The patent is enforceable until 2041 but faces potential challenges based on similar compounds and synthesis methods.
- The patent landscape includes filings in Europe, Japan, and China, with ongoing developments in the core compound class.
- Competitive threats include prior art disclosures that may overlap in structure or use, requiring monitoring of patent filings and publications.
FAQs
1. How broad are the compound claims in U.S. Patent 11,787,815?
The claims are narrow, covering specific structures with defined substitutions, limiting overlap with broad class patents.
2. Can similar compounds infringe this patent?
Only if they match the claimed structures exactly or fall within the scope of the claims, including preparation methods and claimed uses.
3. What is the typical duration of patent protection for this kind of chemical compound?
Generally, 20 years from the earliest filing date, which for this patent is 2021, extending until 2041 assuming maintenance payments.
4. How does the patent landscape influence development of generic versions?
Narrow claims delay generic entry by requiring similar compounds to undergo patent validity challenges; broad claims expedite litigation.
5. Are there opportunities for patent litigation or challenges?
Yes, especially if prior art reveals similar compounds or synthesis methods; challenge proceedings could target novelty or inventive step.
References
[1] U.S. Patent and Trademark Office. (2023). Patent Database. Retrieved from https://www.uspto.gov/patents/search
[2] European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com
[3] Malla, R. (2022). Patent strategies in chemical and pharmaceutical industries. Law Journal of Patent Law, 12(2), 45–62.
